Business Exchange
Sustiva drug interactions.
Publication: HIV Treatment: ALERTS!
Date:Friday, June 1 2007
Subject: Anti-HIV agents (Complications and side effects), Drug interactions (Complications and side effects)
Date:Friday, June 1 2007
Subject: Anti-HIV agents (Complications and side effects), Drug interactions (Complications and side effects)
In January, new precautions were added to the labeling for the "non-nuke" Sustiva concerning potential drug interactions. Patients taking Sustiva should not take Hismanal (astemizole), Vascor (bepridil), Propulsid (cisapride), Versed (midazolam), Orap (pimozide), Halcion (triazolam), or ergot derivatives (for example, Wigraine and Cafergot). Patients could experience serious and life-threatening side effects if Sustiva is taken with one or more of these drugs.
In addition, if combined with Sustiva, the following drugs may require a change in the dose of either Sustiva or the other medicine: Ritadin (ritampin); Sporanox (itraconazole); Nizoral (ketoconazole); calcium-channel blockers (for example, Cardizem, Tiazac, and others); and the cholesterol-lowering medications Lipitor (atorvastatin), Pravachol (pravastatin), and Zocor (simvastatin). Sustiva should not be taken with standard doses of Vfend (voriconazole). However, Sustiva and Vfend can be taken together if dose adjustments are made for both drugs.
In addition, make sure to read these articles:
- Blackberry targeting healthcare
- Free e-prescribing software available
- New safe harbor rules issued for EHS
- The FDA has approved a new version of the...
- From Many, One
- BMS' New Virology Dept. Battles HIV
- Triple nuke nightmare.
- Breast enlargement in men.
- Sustiva warnings.
- Bottom lines: two steps back ...
- US guidelines updated.
- Bristol-Myers Changes DTC Ad Policy
- Q&A: patient/doctor.
- Hypertension risks.
- Good news: the effects of HAART.
In addition, make sure to read these articles:
- Blackberry targeting healthcare
- Free e-prescribing software available
- New safe harbor rules issued for EHS
- The FDA has approved a new version of the anti-HIV drug efavirenz (Sustiva). (FDA Bits).
- From Many, One
- BMS' New Virology Dept. Battles HIV
- Triple nuke nightmare.
- Breast enlargement in men.
- Sustiva warnings.
- Bottom lines: two steps back ...
- US guidelines updated.
- Bristol-Myers Changes DTC Ad Policy
- Q&A: patient/doctor.
- Hypertension risks.
- Good news: the effects of HAART.
In the original Star Trek TV show, communication devices were imbedded in the clothing of Star Fleet crew members. By the 1990s, McDonald's were using ......
National Patient Safety Initiative Launched To Provide Free Electronic Prescribing To Every Physician In America Leading Healthcare and Technology Companies Join in Support of Initiative:Aetna, ......
HHS Secretary Mike Leavitt yesterday announced final regulations that will support physician adoption of electronic prescribing and electronic health records technology. "Electronic health records help ......
* The FDA has approved a new version of the anti-HIV drug efavirenz (Sustiva). The new 600 mg tablet will replace the three 200-mg tablets ......
Three pharmaceutical companies will develop a treatment for AIDS that combines several expensive drugs into a one-pill, once-a-day form. The goal is an easier, more ......
When Bristol-Myers Squibb (BMS) recently acquired Dupont Pharmaceuticals for $7.8 billion, it took control of SUSTIVATM, the No. 1 antiHIV medicine in its class. This ......
Last July, an Important Drug Warning was issued to healthcare providers concerning a high rate of virologic failure with a once-daily, 3-drug combination of Viread, ......
About 2% to 3% of HIV+ men have a condition called gynecomastia (pronounced guy-ni-ko-MAS-tee-uh), which means abnormal breast enlargement. This condition can also occur in ......
New precautions have been added to the labeling for Sustiva regarding interactions with Vfend (voriconazole), a drug used to treat serious fungal infections. Sustiva reduces ......
Trizivir has been marketed as a 1-pill, twice-a-day complete regimen, but this may have been premature. On March 10, 2003, a Notice to Physicians was ......
The Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents is published and updated by the US Department of Health and Human ......
Bristol-Myers Squibb said it would cease advertising drugs directly to consumers during their first year on the market. The client spent $140 million on paid ......
Ben J. Barnett, MD, answers some of the toughest questions from ALERTS/readers yet. Q: I have tried to get vaccinated for Hepatitis B (HepB) with ......
Several studies at the conference looked at the relationship between HIV meds and hypertension (high blood pressure). One study (abstract 872) found that men with ......
With potent combination HIV therapy (or HAART) now almost 10 years old, several long-term studies are showing what effects the meds are having on the ......
Email
Digg It
del.icio.us
Related Resources
Press Releases
- FDA Advisory Panel Recommends Against Approval of Merck's NDA for Non-prescription MEVACOR(R) (lovastatin) 20 mg.
- Andrx to Present Alzheimer's Disease and Diabetes Results at American College of Clinical Pharmacology Meeting.
- Andrx to Present at XIV International Symposium on Drugs Affecting Lipid Metabolism.
